In this episode of Pharmacy Focus, headache specialist Shivang Joshi, MD, MPH, PRh, FAHS discusses the clinical rationale, practical considerations, and pharmacy implications of Symbravo, a fixed-dose combination of meloxicam and rizatriptan approved for acute migraine in adults.
All content for Pharmacy Focus is the property of Pharmacy Times and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Pharmacy Focus, headache specialist Shivang Joshi, MD, MPH, PRh, FAHS discusses the clinical rationale, practical considerations, and pharmacy implications of Symbravo, a fixed-dose combination of meloxicam and rizatriptan approved for acute migraine in adults.
In this episode of Pharmacy Focus, headache specialist Shivang Joshi, MD, MPH, PRh, FAHS discusses the clinical rationale, practical considerations, and pharmacy implications of Symbravo, a fixed-dose combination of meloxicam and rizatriptan approved for acute migraine in adults.
